# Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma

> **NCT01520233** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 100 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **GENETIC:** RNA analysis
- **GENETIC:** gene expression analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01520233
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520233, "Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01520233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*